These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37653753)
1. Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer. Zhang N; Pang C; Li Z; Xu F; Zhao L Medicine (Baltimore); 2023 Aug; 102(34):e34977. PubMed ID: 37653753 [TBL] [Abstract][Full Text] [Related]
2. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430 [TBL] [Abstract][Full Text] [Related]
3. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA. Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378 [TBL] [Abstract][Full Text] [Related]
4. Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer. Pawluczuk E; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680333 [TBL] [Abstract][Full Text] [Related]
5. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874 [TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386 [TBL] [Abstract][Full Text] [Related]
7. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085 [TBL] [Abstract][Full Text] [Related]
8. Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cance. Smycz-Kubańska M; Stępień S; Gola JM; Kruszniewska-Rajs C; Wendlocha D; Królewska-Daszczyńska P; Strzelec A; Strzelczyk J; Szanecki W; Witek A; Mielczarek-Palacz A Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35920183 [TBL] [Abstract][Full Text] [Related]
9. On the issue of diagnostic value of determining the level of receptors and their ligands in blood in non-small cell lung cancer. Murashka DI; Tahanovich AD; Kauhanka MM; Gotko OV; Prokhorova VI Klin Lab Diagn; 2022 May; 67(5):277-285. PubMed ID: 35613346 [TBL] [Abstract][Full Text] [Related]
10. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists. Navarro J Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064 [TBL] [Abstract][Full Text] [Related]
11. Value of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study. Wang RX; Ji P; Gong Y; Shao ZM; Chen S Breast Cancer Res Treat; 2020 Jun; 181(3):561-570. PubMed ID: 32361849 [TBL] [Abstract][Full Text] [Related]
12. Probiotics improve re-epithelialization of scratches infected by Porphyromonas gingivalis through up-regulating CXCL8-CXCR1/CXCR2 axis. Albuquerque-Souza E; Ishikawa KH; Amado PP; Nicoli JR; Holzhausen M; Mayer MPA Anaerobe; 2021 Dec; 72():102458. PubMed ID: 34547426 [TBL] [Abstract][Full Text] [Related]
13. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Varney ML; Johansson SL; Singh RK Am J Clin Pathol; 2006 Feb; 125(2):209-16. PubMed ID: 16393674 [TBL] [Abstract][Full Text] [Related]
14. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287 [TBL] [Abstract][Full Text] [Related]
15. Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis. Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM Cytokine; 2012 Nov; 60(2):473-7. PubMed ID: 22763041 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke. He Q; Shi X; Zhou B; Teng J; Zhang C; Liu S; Lian J; Luo B; Zhao G; Lu H; Xu Y; Lian Y; Jia Y; Zhang Y Mol Immunol; 2018 Sep; 101():440-449. PubMed ID: 30096583 [TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis. Almasi S; Aliparasti MR; Farhoudi M; Babaloo Z; Baradaran B; Zamani F; Sadeghi-Bazargani H; Mostafaei S; Hokmabadi ES Immunol Invest; 2013; 42(8):737-48. PubMed ID: 23876169 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic efficiency of determining CXCR1, CXCR2 and hyaluronic acid blood level in non-small cell lung cancer patients]. Murashka DI; Tahanovich AD; Kauhanka MM; Prokhorova VI; Gotko OV Biomed Khim; 2021 Sep; 67(5):434-442. PubMed ID: 34730557 [TBL] [Abstract][Full Text] [Related]
19. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization. Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468 [TBL] [Abstract][Full Text] [Related]
20. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]